Dicloxacillin
Dicloxacillin is a penicillin-class beta-lactam antibiotic used to treat infections caused by susceptible penicillinase-producing bacteria, particularly Staphylococcus aureus. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial cell death. It is commonly used for skin and soft-tissue infections, including cellulitis, boils, and infected wounds, when the causative organism is susceptible. Dicloxacillin is typically available as oral capsules or other oral formulations, depending on the market. Common side effects include nausea, diarrhoea, abdominal discomfort, and skin rash. It should be used under medical supervision, with particular caution in patients with penicillin allergy; it is not effective against methicillin-resistant Staphylococcus aureus (MRSA).
Dicloxacillin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Dicloxacillin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Dicloxacillin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Dicloxacillin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
